Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
4bases is a private Swiss molecular diagnostics company focused on clinically validated genetic testing solutions for precision medicine. The company develops and sells CE-IVD and IVDR-aligned next-generation sequencing reagent kits, diagnostic protocols, and bioinformatics software for oncology, hereditary disease testing, microbiology, and transplant applications. Its portfolio includes targeted capture-based and amplicon-based assays such as PANCANCER pro, HEMATO pro, CFTR panel, and other multigene panels used by healthcare professionals and clinical laboratories. 4bases positions itself as a platform-oriented diagnostics company rather than a therapeutics developer, with commercial products designed for platform-independent NGS workflows and companion molecular analysis needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 4bases.